Literature DB >> 19086762

Latent structure of the alexithymia construct: a taxometric investigation.

James D A Parker1, Kateryna V Keefer, Graeme J Taylor, R Michael Bagby.   

Abstract

Despite a wealth of research on the validity of alexithymia and its association with a number of common medical and psychiatric disorders, the fundamental question of whether alexithymia is best conceptualized as a dimensional or categorical construct remains unresolved. In the current investigation, taxometric analysis is used to examine the nature of the latent structure of alexithymia. Several nonredundant taxometric procedures were performed with item sets from the 20-item Toronto Alexithymia Scale (R. M. Bagby, J. D. A. Parker, & G. J. Taylor, 1994) as indicators. These procedures were applied separately in large community (n = 1,933) and undergraduate (n = 1,948) samples and in a smaller sample of psychiatric outpatients (n = 302). The results across various taxometric procedures and the different samples provide strong support that alexithymia is a dimensional construct. Some theoretical implications of these findings for research on the alexithymia construct are discussed. (c) 2008 APA, all rights reserved.

Entities:  

Mesh:

Year:  2008        PMID: 19086762     DOI: 10.1037/a0014262

Source DB:  PubMed          Journal:  Psychol Assess        ISSN: 1040-3590


  26 in total

1.  Is alexithymia related to colon cancer? A survey of patients undergoing a screening colonoscopy examination.

Authors:  M Lauriola; A Panno; M Tomai; V Ricciardi; A E Potenza
Journal:  J Clin Psychol Med Settings       Date:  2011-12

2.  Error monitoring is related to processing internal affective states.

Authors:  Martin E Maier; Cristina Scarpazza; Francesca Starita; Roberto Filogamo; Elisabetta Làdavas
Journal:  Cogn Affect Behav Neurosci       Date:  2016-12       Impact factor: 3.282

3.  The relationship of alexithymia to emotional dysregulation within an alcohol dependent treatment sample.

Authors:  Paul R Stasiewicz; Clara M Bradizza; Gregory D Gudleski; Scott F Coffey; Robert C Schlauch; Sydney T Bailey; Christopher W Bole; Suzy Bird Gulliver
Journal:  Addict Behav       Date:  2011-12-27       Impact factor: 3.913

4.  Measuring Alexithymia via Trait Approach-I: A Alexithymia Scale Item Selection and Formation of Factor Structure.

Authors:  Arkun Tatar; Gaye Saltukoğlu; Seda Alioğlu; Sümeyye Çimen; Hülya Güven; Çağla Ebru Ay
Journal:  Noro Psikiyatr Ars       Date:  2016-09-01       Impact factor: 1.339

5.  Interactions between the salience and default-mode networks are disrupted in cocaine addiction.

Authors:  Xia Liang; Yong He; Betty Jo Salmeron; Hong Gu; Elliot A Stein; Yihong Yang
Journal:  J Neurosci       Date:  2015-05-27       Impact factor: 6.167

6.  Brain potentials to emotional pictures are modulated by alexithymia during emotion regulation.

Authors:  Sarah Walker; Daryl B O'Connor; Alexandre Schaefer
Journal:  Cogn Affect Behav Neurosci       Date:  2011-12       Impact factor: 3.282

7.  Alexithymia and Addiction: A Review and Preliminary Data Suggesting Neurobiological Links to Reward/Loss Processing.

Authors:  Kristen P Morie; Sarah W Yip; Charla Nich; Karen Hunkele; Kathleen M Carroll; Marc N Potenza
Journal:  Curr Addict Rep       Date:  2016-04-11

8.  Insula's functional connectivity with ventromedial prefrontal cortex mediates the impact of trait alexithymia on state tobacco craving.

Authors:  Matthew T Sutherland; Allison J Carroll; Betty Jo Salmeron; Thomas J Ross; Elliot A Stein
Journal:  Psychopharmacology (Berl)       Date:  2013-02-28       Impact factor: 4.530

9.  Neurocognitive correlates of alexithymia in asymptomatic individuals with HIV.

Authors:  Yelena Bogdanova; Mirella Díaz-Santos; Alice Cronin-Golomb
Journal:  Neuropsychologia       Date:  2009-12-28       Impact factor: 3.139

Review 10.  The Prevalence and Characteristics of Alexithymia in Adults Following Brain Injury: A Meta-Analysis.

Authors:  Danielle M Fynn; Gilles E Gignac; Rodrigo Becerra; Carmela F Pestell; Michael Weinborn
Journal:  Neuropsychol Rev       Date:  2021-02-23       Impact factor: 7.444

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.